AnaptysBio, Inc. short interest in 2020
In 2020, AnaptysBio, Inc.'s disclosed short interest ran from 16.28% of shares outstanding on 15 Jan 2020 to 12.89% on 31 Dec 2020, a change of -3.39 percentage points. The year's high was 22.92% on 15 Apr 2020 and its low 12.89% on 31 Dec 2020, averaging 18.26% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.04 days on 31 Jul 2020. Full history: AnaptysBio, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 16.28% (15 Jan 2020)
- End of year
- 12.89% (31 Dec 2020)
- Change
- -3.39 pp
- High
- 22.92% (15 Apr 2020)
- Low
- 12.89% (31 Dec 2020)
- Average
- 18.26%
- Highest days to cover
- 30.04 (31 Jul 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 16.28% | 9.06 | |
| 31 Jan 2020 | 18.55% | 10.37 | |
| 14 Feb 2020 | 19.33% | 10.89 | |
| 28 Feb 2020 | 20.68% | 8.41 | |
| 13 Mar 2020 | 21.87% | 8.62 | 10-K filed, results (8-K) |
| 31 Mar 2020 | 22.81% | 9.68 | |
| 15 Apr 2020 | 22.92% | 13.24 | |
| 30 Apr 2020 | 22.42% | 17.47 | |
| 15 May 2020 | 22.89% | 16.58 | 10-Q filed, results (8-K) |
| 29 May 2020 | 21.83% | 20.78 | |
| 15 Jun 2020 | 21.35% | 14.44 | |
| 30 Jun 2020 | 18.79% | 11.41 | |
| 15 Jul 2020 | 18.50% | 27.23 | |
| 31 Jul 2020 | 17.86% | 30.04 | |
| 14 Aug 2020 | 17.48% | 28.41 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 16.84% | 28.87 | |
| 15 Sep 2020 | 16.91% | 22.78 | |
| 30 Sep 2020 | 15.75% | 16.01 | |
| 15 Oct 2020 | 16.31% | 13.09 | |
| 30 Oct 2020 | 14.44% | 7.86 | |
| 13 Nov 2020 | 14.53% | 11.31 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 13.74% | 14.63 | |
| 15 Dec 2020 | 13.33% | 16.82 | |
| 31 Dec 2020 | 12.89% | 17.33 |
See also: AnaptysBio, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.